Koninklijke Philips N.V. reports health technology developments across Diagnosis & Treatment, Connected Care and Personal Health. News from Royal Philips commonly covers order intake and comparable sales trends; product launches and regulatory clearances for imaging, image-guided therapy and AI software; and governance actions from its Annual General Meeting. Recent product themes include CT platforms such as Rembra and Spectral CT Verida, interventional guidance tools such as DeviceGuide and IntraSight Plus, and the Bridge Plus Occlusion Balloon for lead extraction procedures.
The company’s updates also address hospital monitoring, informatics, ultrasound, oral health and personal-care lines. Coverage reflects Philips’ role as a Netherlands-based global health technology company with securities traded on NYSE under PHG and on Euronext Amsterdam under PHIA.
Philips (PHG) reported third-quarter 2026 sales of EUR 4.4 billion, with comparable growth and higher adjusted margins across all business segments.
Comparable sales rose 3% and comparable order intake grew 8%. Income from operations was EUR 165 million. Adjusted EBITA margin increased 70 basis points to 13.0%. Operating cash flow increased to EUR 544 million, and free cash flow increased to EUR 384 million.
Diagnosis & Treatment comparable sales were flat; Connected Care grew 5% and Personal Health grew 8%. Productivity initiatives delivered EUR 170 million in quarterly net savings. Philips reiterated its 2026 outlook for comparable sales growth of 3%-4.5%, adjusted EBITA margin of 13.5%-14.0% and free cash flow of EUR 1.5-1.7 billion. The company also issued EUR 650 million in fixed-rate notes due 2034.
Royal Philips (PHG) announced U.S. commercial availability of HyperVue Integrated, a fixed system combining coronary imaging and physiology assessment in one room. The configuration is permanently installed in a dedicated interventional suite, unlike the mobile version that must be moved, powered and connected for each procedure. It combines DeepOCT+NIRS imaging inside coronary arteries with X1-FFR, an angiography-based tool for assessing coronary physiology. Philips says the fixed installation is designed to reduce setup steps and keep these tools readily available.
HyperVue Integrated is a form factor of the FDA-cleared HyperVue Imaging System – Integrated product. Philips will showcase it alongside X1-FFR and its U.S.-available IntraSight Plus guidance platform at TCT 2026 in San Diego, October 31–November 3.
Royal Philips (NYSE: PHG) launched CE-marked UniGuide 3D Live Guidance, available for sale in CE-marked markets from October 23, 2026.
The solution brings planning information derived from computed tomography (CT) scans into the live workflow of Philips' Azurion image-guided therapy platform. Its first release supports coronary interventions, structural heart procedures and complex vascular procedures. Physicians can view CT information through 3D overlays or synchronized side-by-side displays. UniGuide supports planning from Philips Advanced Visualization Workspace and compatible third-party solutions. It is not currently available for sale in the United States.
Philips intends to expand this approach across additional imaging methods, clinical applications and procedure types over time.
Philips (PHG) has launched the Lumea 9900 Pro, an at-home light-based hair removal device that provides guided treatments.
The device is now available at a recommended retail price of EUR 799.99. Its app provides real-time audio feedback and visual guidance. Philips identifies personalized guidance, confidence-building support and more human-feeling technology as trends expected to shape beauty routines by 2027. These are perspectives on future consumer preferences, rather than reported business results.
Royal Philips (PHG) published Norelco OneBlade research finding that gaming characters inspire real-world appearance choices among surveyed U.S. male gamers. The research found that 80% of U.S. male gamers ages 18–45 have taken appearance inspiration from gaming avatars or characters, while 51% wish they looked more like their avatar.
Among the findings, 93% believe greater grooming effort would improve their confidence, and 75% report at least one barrier to putting more effort into their appearance. Cost was cited by 30%, lack of priority by 27%, insufficient time by 24% and not knowing where to start by 21%. The announcement pairs the survey with promotion of OneBlade grooming tools.
Royal Philips (PHG) highlighted plans to strengthen its cardiovascular informatics portfolio following its acquisition of MediReport, ahead of TCT 2026.
Philips expects MediReport’s reporting and workflow capabilities to complement its existing systems and support its longer-term direction toward cloud-ready, AI-enabled cardiovascular care. MediReport 360 supports structured documentation and real-time reporting before, during and after procedures. It allows clinical information to be captured once and reused for reports, coding, registries and follow-up.
MediReport’s technologies support cloud and on-premises deployment and interfaces with imaging, hemodynamic and hospital IT systems. The expected enhancement would build on Philips’ existing cardiovascular image management, ultrasound reporting and catheterization-lab information tools.
Royal Philips (NYSE: PHG) launched EXIT-CVD, a five-year cardiovascular research project co-led with University Medical Center Groningen. The consortium brings together 42 partners across 17 countries and plans 22 clinical studies involving more than 14,000 patients across Europe. Enrollment for the first studies will begin in October 2026. The project has a total budget of EUR 27.6 million, co-funded by the European Union Innovative Health Initiative and industry partners.
The consortium aims to prevent cardiovascular disease, reverse its progression or halt progression in advanced stages through earlier detection and personalized interventions. Research includes digital monitoring, cardiac imaging and remote heart failure monitoring. Interventions will be co-created with patients and designed to address socioeconomic, sex- and gender-related and digital access gaps.
Royal Philips (PHG) has formed the Philips Sonicare Global Clinical Advisory Board to advise its oral healthcare business.
The board comprises 12 international dental experts spanning clinical practice, research, education, behavior change and digital dentistry. Philips intends the board to provide guidance on emerging trends, support science-led product development and contribute to clinical exploration. The collaboration is designed for ongoing exchange with external experts and to incorporate dental professionals’ perspectives into the oral healthcare product roadmap.
Royal Philips (PHG) has made its Sonicare Next-Generation DiamondClean 9900 Prestige toothbrush available on Amazon at a price of $379.99. Unveiled in July 2026, the model provides brushing guidance directly on its handle without requiring an app. Its 12-segment mouth map shows cleaned areas and missed spots, while a light ring provides feedback on coverage, pressure and scrubbing patterns.
The 9900 Prestige offers eight modes and three intensity settings, with pressure sensing that automatically adjusts intensity. The Next-Generation DiamondClean 8500 is also available on Amazon for $249.99, offering six modes and three intensity settings. Both models include a rechargeable travel case and charging glass, and use paper-based packaging.
Philips (PHG) and Southwest Mississippi Regional Medical Center (SMRMC) announced the installation of the first Philips Rembra CT system for acute and high-demand imaging environments in the United States.
The FDA 510(k)-cleared Rembra CT is designed to accelerate scanning and image reconstruction, potentially reducing time patients spend on the table and supporting timely decisions in emergency and trauma care. Throughput testing indicates the system can support up to 270 patient exams per day over a 16-hour day, helping manage growing imaging volumes. With an 85 cm bore, described as largest-in-class, and AI-enabled workflows, the system aims to improve access, positioning and workflow efficiency, expanding advanced diagnostic services for patients in southwest Mississippi.